Delivery Order SPE2DR25D3014-SPE2DR26FP1DR
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,051.05 firm fixed-price delivery order on June 17, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 ml pens. This delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,414.82. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded without a set-aside designation through competitive procurement. Performance will be executed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,017.52 by the Defense Logistics Agency on November 24, 2025, with completion targeted for November 25, 2025. The contract (4570091594) involves the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL), a diabetes medication commonly used within military and federal healthcare systems. This delivery order was competitively awarded without set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,878.61 by the Defense Logistics Agency (DLA) on September 18, 2025, with a completion date of September 19, 2025. The contract covers the supply of Trulicity 1.5 mg/0.5 mL pen injectable medication, a diabetes treatment. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 1.5 mg/0.5 ml pens with a ceiling value of $3,877.77. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, is structured as a firm fixed price contract with no set-aside designation. This award represents a competitive procurement action under the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,907.40 by the Defense Logistics Agency (DLA) on November 24, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. This firm fixed price, non-set-aside contract is designated as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 5, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $4,088.04. The award is structured as a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens with a ceiling value of $1,366.59. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 8, 2025, and performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order...
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP1DRDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,453.70. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 26, 2025, and will be performed at the awardee's facility in Conshohocken, PA. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion through December 2026 and serves as the primary vehicle for pharmaceutical support across military healthcare systems worldwide. This delivery order exemplifies AmerisourceBergen's ongoing role as a critical pharmaceutical vendor to the federal government, particularly for the Defense Health Agency and military medical supply chains. The company's extensive portfolio includes diabetes medications, neurological treatments, pain management pharmaceuticals, vaccines, and other specialized medical supplies. The award reflects DLA's continued reliance on AmerisourceBergen's capability to deliver competitively awarded medical commodities that support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/24/25 |